M. Kobayashi

Recent Advances in the Management of Chronic Hepatitis B Including Suppression of Hepatocellular Carcinoma by Entecavir and Interferon

M. Kudo, S. Kim, Y. Hiramatsu, 2015, Oncology.

Contents Vol. 34, 2016

Y. Imai, M. Kudo, Y. Minami, 2016, Digestive Diseases.

Efficacy and Safety of Sofosbuvir Plus Ribavirin Treatment for Patients with Chronic Hepatitis C Genotype 2

M. Kudo, Yasuhito Tanaka, Y. Yano, 2016, Digestive Diseases.

Comparison of Sofosbuvir Plus Ribavirin Treatment with Pegylated Interferon Plus Ribavirin Treatment for Chronic Hepatitis C Genotype 2

M. Kudo, Y. Yano, Y. Hayashi, 2017, Digestive Diseases.

A phase Ib trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) in unresectable hepatocellular carcinoma (uHCC): Updated results

M. Kudo, S. Kaneko, J. Llovet, 2019, Annals of Oncology.

All-case Japanese post-marketing surveillance of the real-world safety and efficacy of rituximab treatment in patients with refractory nephrotic syndrome

T. Ando, Mana Kobayashi, Yutaro Kageyama, 2021, Clinical and Experimental Nephrology.